medigraphic.com

2021, Number 2

<< Back Next >>

Rev Fac Med UNAM 2021; 64 (2)

Von Willebrand's Disease as a Risk Factor for Postpartum Hemorrhage. Case Report

Chavira ACF, Arriaga LA, Álvarez TA

Language: Spanish
References: 22
Page: 31-37
PDF size: 217.08 Kb.


ABSTRACT

The Von Willebrand´s disease is the most common inherited bleeding disorder, with higher prevalence in women in fertile age. There are three principle types, that are caused by either a quantitative or qualitative defect in von Willebrand factor and in severe cases, the coagulation factor VIII is affected too. The incidence in pregnancy is relatively infrequent, however there are worldwide reports where it has been considered a risk factor for bleeding during the resolution of pregnancy. We present the case of a 20-year-old woman on her second pregnancy, with a previous abortion, who had a full-term pregnancy with a diagnosis of Von Willebrand disease since she was twelve years old, treated with nasal desmopressin only in the presence of hemorrhagic events. Gestation was terminated via abdominal route due to failed induction, and in spite of preoperative hematologic and anesthetic prophylactic management, she presented postpartum hemorrhage, according to current definitions based on national and interhttp national guidelines, attributing the cause of the bleeding to the patient's coagulopathy.


REFERENCES

  1. Reynen E, James P. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion. Semin Thromb Hemost. 2016;42(7):717-23.

  2. Committee Opinion. Von Willebrand Disease in Women. The American College of Obstetricians and Gynecologist. 2013;580:1-6.

  3. Simionescu A, Biunoiu N, Berbec N. Von Willebrand Disease type 2 in pregnancy: A critical clinical association. Transfus Apheresis Sci. 2017;1-3.

  4. Espitia F. Manejo de la enfermedad de Von Willebrand en Ginecología y obstetricia: Revisión Cualitativa de la literatura. Rev Colomb Obstet Ginecol. 2010;61:151-9

  5. Majluf A, Velez MA, González A, García J, Berges A, López N, et al. Von Willebrand Disease in México: A pilot study. Haemophilia. 2013;19(2):231-5.

  6. Roth Ch, Syed L. Von Willebrand Disease in Pregnancy. Nur Womens. 2016;20(5):501-5.

  7. Woods A, Blanco A, Kempfer A, Paiva J, Bermejo E, Sánchez A, et al. Factor von Willebrand y Enfermedad de von Willebrand: nuevos enfoques diagnósticos. Acta Bioquím Clín Latinoam. 2016;50(2):273-89.

  8. James A. Von Willebrand disease in women: awareness and diagnosis. Thromb Res. 2009;124(1):7-10.

  9. Ojeda J, Rodríguez M, Estepa J, Piña C, Cabeza B. Cambios fisiológicos durante el embarazo. Su importancia para el anestesiólogo. MediSur. 2011;9(5):484-91.

  10. Schneppenheim R. The pathophysiology of von Willebrand disease: therapeutic implications. Thromb Res. 2011;128(1): 3-7.

  11. Purizaca M. Modificaciones fisiológicas en el embarazo. Rev Per Ginecol Obstet. 2010;56(1):57-69.

  12. Pacheco L, Constantine M, Saade G, Mucowski S, Hankins G, Sciscione A. Von Willebrand Disease in pregnancy. Am J Obstet Gynecol. 2010:203(3):194-200.

  13. Govorov I, Logren S, Chaireti R, Holmstrom M, Bremme K, Mints M. Postpartum Hemorrhage in Women with Von Willebrand Disease: A Retrospective Observational Study. PlosONE. 2016;11(10):1-14.

  14. Huq F, Kadir R. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia. 2011;17:20-30.

  15. James A, Jamison M. Bleeding events and other complications during pregnancy and childbirth in women with Von Willebrand Disease. J Thromb Haemost. 2007;5:1165-9.

  16. James A, Kouides P, Abdul R, Edlund M, Federici A, Halimeh S, et al. Von Willebrand Disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009;201(1):12-8.

  17. Prevención y Manejo de la Hemorragia Obstétrica en el primero, segundo y tercer nivel de atención. Resumen de Evidencias y Recomendaciones. Guía de Práctica clínica de enfermería. México, Secretaría de Salud. CENETEC; 2017.

  18. Borovac A, Pacagnella RC, Cecatti JG, Miller S, Ayadi AM, Souza JP, et al. Postpartum hemorrhage: new insights for definition and diagnosis. Am J Obstet Gynecol. 2018;219(2):162-8.

  19. Guerrero MC, Escárcega LR, González OA, Palomares A, Gutiérrez CH, et al. Utilidad del índice de choque como valor predictivo para el requerimiento de trasfusión en hemorragia obstétrica. Ginecol Obstet Mex. 2018; 86(10):665-74.

  20. Chee Y, Townend J, Crowther M, Smith N, Watson H. Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage. Haemophilia. 2012;1-5.

  21. 2Corona A, García K, Camarena E, López LJ, González J, Fajardo S. Indicaciones del factor VII recombinante activado en hemorragia obstétrica grave. Ginecol Obstet Mex. 2018;86(12):779-86.

  22. McLaughlin D, Kerr R. Management of Type 2B von Willebrand Disease during Pregnancy. Acta Haematol. 2017;137(2):89-92.




2020     |     www.medigraphic.com